Clinical utility of a dipstick assay in patients with brucellosis: correlation with the period of evolution of the disease.

Authors: Casao MA,Smits HL,Navarro E,Solera J,
Address: Experimental Research Unit, General Hospital of Albacete, Albacete, Spain.
Journal: Clin Microbiol Infect.


Publication: 2003 Apr;9(4):301-5.

abstract

To examine the Clinical utility of a dipstick assay for the detection of Brucella-specific IgM antibodies, and the correlation with the evolution of the disease. Twenty-six patients who were admitted to the General Hospital of Albacete (Spain) over a 2-year period and diagnosed with brucellosis were included in the study. One hundred and twenty-five serum samples collected at the time of diagnosis and at intervals during and after treatment were tested by the Coombs test, the standard seroagglutination test (SAT), the SAT in the presence of dithiothreitol (DTT-SAT), and a dipstick assay for the detection of Brucella-specific immunoglobulin M (IgM) antibodies. The sensitivity of the dipstick assay at the moment of the diagnosis was similar to that of the SAT (62% and 73%, respectively), somewhat higher than that of the DTT-SAT (50%), and lower than that of the Coombs test (100%). Patients with a negative dipstick test at the moment of diagnosis displayed a period of evolution of the disease longer than that of the dipstick-positive patients. After the beginning of therapy, the detection rate of the dipstick assay decreased faster than those of the SAT, the DTT-SAT, and the Coombs test. Thirty days after the start of therapy, the detection rate of the dipstick assay had decreased to 7%, whereas that of the SAT and DTT-SAT was 46%, and that of the Coombs test was still 92%. The dipstick assay could be used as a rapid diagnostic test for patients in the early stages of illness. Patients with a long period of illness will probably have a negative dipstick test, and could be diagnosed with the aid of the Coombs test and classical clinical findings.



Related Articles
Evaluation of Brucellacapt for the diagnosis of human brucellosis.
J Infect. 2004
Evaluation of Brucellacapt for the diagnosis of human brucellosis.
Casao MA, Navarro E, Solera J. J Infect. 2004 Aug; 49(2):102-8.
Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis.
Clin Diagn Lab Immunol. 2003
Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis.
Clavijo E, Díaz R, Anguita A, García A, Pinedo A, Smits HL. Clin Diagn Lab Immunol. 2003 Jul; 10(4):612-5.
Evaluation of Brucella dipstick assay for the diagnosis of acute brucellosis.
Diagn Microbiol Infect Dis. 2002
Evaluation of Brucella dipstick assay for the diagnosis of acute brucellosis.
Altuglu I, Zeytinoğlu A, Bilgic A, Kamcioglu S, Karakartal G, Smits H. Diagn Microbiol Infect Dis. 2002 Nov; 44(3):241-3.
Review [The value of culture and serological methods in the diagnosis of human brucellosis].
Mikrobiyol Bul. 2008
Review [The value of culture and serological methods in the diagnosis of human brucellosis].
Alişkan H. Mikrobiyol Bul. 2008 Jan; 42(1):185-95.
Review Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature.
Rev Infect Dis. 1991
Review Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature.
Young EJ. Rev Infect Dis. 1991 May-Jun; 13(3):359-72.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.